HERPES VIRUS (HHV 2) - ANVISA Registration 10287411066

Access comprehensive regulatory information for HERPES VIRUS (HHV 2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10287411066 and manufactured by ROCHE MOLECULAR SYSTEMS, INC. The registration is held by ROCHE DIAGNÓSTICA BRASIL LTDA with validity until Nov 03, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including DIASORIN ITALIA S.P.A., ORGENTEC DIAGNOSTIKA GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10287411066
2 Related Devices
Registration Details
ANVISA Registration Number: 10287411066
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

HSV 1 and 2 Controls and Cofactor Kit
Risk Class III

Registration Details

10287411066

25351415484201471

30280358000186

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Nov 03, 2014

03/11/2034

09/18/2025 19:00:01

HSV 1 and 2 Controls and Cofactor Kit
Risk Class III

Registration Details

10287411066

25351415484201471

30280358000186

Company Information

Dates and Status

Nov 03, 2014

03/11/2034

09/18/2025 19:00:01